The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Open accessAbstract
OBJECTIVE: Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes. RESULTS: The magnitude of weight loss at 1 year was strongly (P < 0.0001) associated with improvements in glycemia, blood pressure, tryiglycerides, and HDL cholesterol but not with LDL cholesterol (P = 0.79). Compared with weight-stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]). The odds of clinically significant improvements in most risk factors were even greater in those who lost 10–15% of their body weight. CONCLUSIONS: Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“behavioral weight loss (BWL) is the gold-standard non-surgical treatment for weight loss”
From Associations Between Self-Monitoring and Weight Change in Behavioral Weight Loss Interventions (2019) · cites this paper as Wing et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss across a spectrum of elevated BMIs produces not only improvements in glucose levels and the traditional cardiovascular intermediate risk factors 28 but also reductions in ectopic adipose tissue depots that may contribute to atherosclerosis and myocardial dysfunction. 29”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These reductions are associated in a generally linear manner with improvements in cardiovascular disease (CVD) risk factors, quality of life, and prevention of type 2 diabetes [24–26].”
From The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities (2023) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people living with obesity, losing 5% to 10% of body weight can lead to a substantial reduction in risk factors for diabetes, cardiovascular disease, and stroke [8].”
From Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It should be noted, however, that the clinical benefits of weight loss are progressive, and more intensive weight loss goals (i.e., 15%) may be appropriate to maximize benefit depending on need, feasibility, and safety (106,107).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [107]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
(1998) · PubMed · Cited by 2,737
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Self-citationThe Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873
The Look AHEAD Research Group (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00064-3 · Cited by 767
Wood, P. D., Stefanick, M. L., Williams, P. T., & Haskell, W. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250703 · Cited by 520
Effect of Degree of Weight Loss on Health Benefits
Blackburn, G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00466.x · Cited by 503
Roizen, M. F. (2011) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2011.01.029 · Cited by 487
Long-term Effects of Modest Weight Loss in Type II Diabetic Patients
Wing, R. R. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370100063012 · Cited by 484
Self-citation&NA; (1992) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199203000-00003 · Cited by 453
Short-Term Medical Benefits and Adverse Effects of Weight Loss
Pi-Sunyer, F. X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00019 · Cited by 392
The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
Kris-Etherton, P. M., Krummel, D., Russell, M. E., Dreon, D., Mackey, S., Borchers, J., & Wood, P. D. (1988) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)08023-8 · Cited by 303
Relative effects of calorie restriction and weight loss in noninsulin- dependent diabetes mellitus
Kelley, D. E. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1287 · Cited by 303
Self-citationWeighing the Options: Criteria for Evaluating Weight-Management Programs
Thomas, P. (2013) · Cited by 285
Poobalan, A., Aucott, L., Smith, W. C. S., Avenell, A., Jung, R., Broom, J., & Grant, A. M. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00127.x · Cited by 240
Updated review on the benefits of weight loss
Vidal, J. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802215 · Cited by 188
Siöström, C. D., Lissner, L., & Siostrom, L. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00572.x · Cited by 179
Weighing the options: Criteria for evaluating weight-management programs.
(1995) · National Academies Press eBooks · doi:10.1037/10510-000 · Cited by 173
Horvath, K., Jeitler, K., Siering, U., Stich, A. K., Skipka, G., Gratzer, T. W., & Siebenhofer, A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.571 · Cited by 161
Jeffrey, R. W., Wing, R., & Mayer, R. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.4.641 · Cited by 155
Self-citationWing, R. R., & Jeffery, R. W. (1995) · PubMed · Cited by 144
Jeffrey, R. W., Wing, R. R., & Mayer, R. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.4.641 · Cited by 142
Self-citationWadden, T. A., Anderson, D. A., & Foster, G. D. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00699.x · Cited by 129
Self-citationWhat is the relationship between risk factor reduction and degree of weight loss?
Gaal, L. F. V., Mertens, I. L., & Ballaux, D. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui082 · Cited by 111
Before oral agents fail: the case for starting insulin early
Marre, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802174 · Cited by 44
Institute of Medicine (1995) · National Academies Press eBooks · doi:10.17226/4756 · Cited by 41
Cited by
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Self-citationKernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Self-citationKleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Metadata
- Authors
- Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., & the Look AHEAD Research Group
- Affiliations
- Brown University (US)
- Wake Forest University Health Sciences (US)
- University of Pennsylvania (US)
- University of Alabama at Birmingham (US)
- National Institutes of Health (US)
- University of Colorado Health (US)
- Johns Hopkins University (US)
- Roybal Comprehensive Health Center, Los Angeles, California
- Corresponding author
- Wing, Rena R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-06-17
- Volume
- 34
- Issue
- 7
- Pages
- 1481-1486
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3120182
- OpenAlex
- W2096048424
- Semantic Scholar
- e255352983f0832ba4b41a003633e20e137c2853
- Cited by
- 1,828
- References
- 31
- Citations by year
- 2026: 86 · 2025: 153 · 2024: 136 · 2023: 145 · 2022: 146 · 2021: 143 · 2020: 139 · 2019: 146 · 2018: 126 · 2017: 125 · 2016: 137 · 2015: 99 · 2014: 104 · 2013: 80 · 2012: 49
- FWCI
- 64.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- weight loss, type 2 diabetes, cardiovascular risk factors, obesity, overweight, Look AHEAD trial, glycemic control, HbA1c, blood pressure, triglycerides, HDL cholesterol, LDL cholesterol
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Education as Topic, Risk Factors, Weight Loss, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.